Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
2.3.6 Literatur
Adrian TE, Mitchenere P, Sagor G, Bloom SR (1982) Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. Am J Physiol 243: G204–G207
Ahlman H, Nilsson O (2001) The gut as the largest endocrine organ in the body. Ann Oncology 12: S63–S68
Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240–244
Anastasi A, Erspamer V, Bucchi M (1971) Isolation and structure of bombesin and alytensin, two analogues active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27: 166–167
Aziz Q, Thompson DG (1998) Brain-gut axis in health and disease. Gastroenterology 114: 559–578
Barelli H, Vincent JP, Checler F (1988) Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. Eur J Biochem 175: 481–489
Batterham RL, Bloom SR (2003) The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 994: 162–168
Baum RP, Hofmann M (2004) Nuklearmedizinische Diagnostik neuroendokriner Tumoren. Onkologe 10: 598–610
Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28: 325–353
Bayliss WM, Starling EH (1904) Croonian lecture. The chemical regulation of the secretory process. Proc R Soc 73: 310–332
Bednarek M, Feighner SD, Pong SS et al. (2000) Structure-function studies on the new growth-hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth-hormone secretagogue receptor la. J Med Chem 43: 4370–4376
Bell GI, Sanchez Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304: 368–371
Benali N, Cordelier P, Calise D et al. (2000) Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci USA 97: 9180–9185
Berson SA, Yalow RS (1972) Radioimmunoassays in gastroenterology. Gastroenterology 62: 1061–1069
Bowers CY, Momany FA, Reynolds GA, Hong A (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth-hormone. Endocrinol 114: 1537–1545
Brand SJ, Babyatsky M, Bachwich D, Tillotson L, Wang T (1994) Molecular approaches to the study of gut peptides. In: Walsh JH, Dockray GJ (eds) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 11–32
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77–79
Bresnahan PA, Leduc R, Thomas L et al. (1990) Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol 111: 2851–2859
Broglio F, Arvat E, Benso A et al. (2001) Ghrelin, a natural GH scretagogue produced by the stomach, induces hyperglycaemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86: 5083–5086
Broglio F, Gottero C, Arvat E, Ghigo E (2003) Endocrine and non-andocrine actions of ghrelin. Horm Res 59: 109–117
Bucceri AM, Calogero AE, Brogna A (2002) Gallbladder and gastric emptying: relation to cholecystokininemia in diabetics. Eur J Intern Med 13: 123–128
Bunnett N (1994) Gastrin-releasing peptide. In: Walsh JH, Dockray GJ (eds) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 423–446
Caixas A, Bashore C, Nash W (2002) Insulin, unlike food in-take, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87: 1902–1906
Cao T, Pinter E, Al-Rashed S et al. (2000) Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal cutaneous microvasculature: An in vivo study using neurokinin-1 receptor knockout mice. J Immunol 164: 5424–5429
Casanueva FF, Dieguez C (1999) Growth-hormone secretagogues: Physiological role and clinical utility. Trends Endocrinol Metab 10: 30–38
Chang MM, Leeman SE (1970) Isolation of a sialagogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 245: 4784–4790
Checler F, Ahmad S, Kostka P et al. (1987) Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensin. Eur J Biochem 166: 461–468
Chiba T, Yamada T (1994) Gut somatostatin. In: Walsh JH, Dockray GJ (eds) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 123–145
Claing A, Perry SJ, Achiriloaie M, Walker JK, Albanesi JP, Lefkowitz RJ, Premont RT (2000) Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci USA 97: 1119–1124
Conlon JM (1993) Proteolytic inactivation of neurohormonal peptides in the gastrointestinal tract. In: Brown DR (ed) Gastrointestinal regulatory peptides. Springer, Heidelberg, pp 177–198
Creutzfeldt W (1996) Carcinoid tumors: Development of our knowledge. World J Surg 20: 126–131
Creutzfeldt W, Ebert R (1985) New developments in the incretin concept. Diabetologia28: 565–573
Creutzfeldt W, Nauck M (1992) Gut hormones and diabetes mellitus. Diab Metab Rev 8: 149–177
Daaka Y, Luttrell LM, Lefkowitz RJ (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88–91
Damholt AB, Kofod H, Buchan AM (1999) Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intesine. Cell Tissue Res 298: 287–293
Danielsen EM, Vyas JP, Kenny AJ (1980) A neutral endopeptidase in the microvillar membrane of pig intestine. Partial purification and properties. Biochem J 191: 645–648
Date Y (2000) Ghrelin, a novel growth-hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141: 4255–4261
Davis RJ (1995) Transcriptional regulation by MAP kinases. Mol Reprod Devel 42: 459–467
De Maturana RL, Willshaw A, Kuntsch A, Rudolph R, Donelly D (2003) The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptids with much higher affinity than GLP-1. J Biol Chem 278: 10195–10200
Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Hoist JJ (1995) Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH 2-terminus in type 2-diabetic patients and in healthy subjects. Diabetes 44: 1126–1131
Del Rincon JP, Thorner MO, Gaylinn BD (2001) Motilin-related peptide and ghrelin: Lessons from molecular techniques, peptide chemistry, and receptor biology. Gastroenterology 120: 587–588
Deprez PH, Sempoux C, De Saeger C, Rahier J, Mainguet P, Pauwels S, Geubel A (2002) Expression of cholecystokinin in the duodenum of patients with celiac disease: Respective role of atrophy and lymphocytic infiltration. Clin Sci (Lond) 103: 171–177
Ding WQ, Kuntz S, Bohmig M, Wiedenmann B, Miller LJ (2002) Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. Gastroenterology 122: 500–511
Dockray GJ (1994 a) Substance P and other tachykinins. In: Walsh JH and Dockray GJ (eds) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 401–422
Dockray GJ (1994 b) Vasoactive intestinal polypeptide and related peptides. Gut peptides: Biochemistry and Physiology, JH Walsh, GJ Dockray (Hrsg.). Raven Press, New York 447–492
Dockray GJ, Varro A, Dimaline R, Wang T (2001) The Gastrins: Their production and biological activities. Ann Rev Phys 63: 119–139
Drucker DJ (2001) Glucagon-like peptide 2. J Clin Endocrinol Metab 86: 1759–1764
Drucker DJ (2003) Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17: 161–171
Dupre J, Ross SA, Watson D, Brown JC (1973) Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 37: 826–828
Edkins JS (1905) On the chemical mechanisms of gastric secretion. Proc R Soc Lond B Biol Sci 76: 376
Eissele R, Göke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Göke B (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract of rat, pig and man. Eur J Clin Invest 22: 283–291
Erdos EG, Skidgel RA (1987) The angiotensin I-converting enzyme. Lab Invest 56: 345–348
Fahrenkrug J (1993) Transmitter role of vasoactive intestinal peptide. Pharmacol Toxicol 72: 354–363
Fahrenkrug J, Schaffalitzky de Muckadell OB (1977) Plasma secretin concentration in man: effect of intraduodenal glucose, fat, amino acids, ethanol, HCl or ingestion of a meal. Eur J Clin Invest 7: 201–203
Fehmann HC, Göke B (1997) The insulinotropic gut hormone glucagon-like peptide 1. Frontiers Diabetes 13: 1–240
Fehmann HC, Habener JF (1992) Insulinotropic hormone glucagon-like peptide-1 (7–37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130: 159–166
Fehmann HC, Göke R, Göke B (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulin releasing polypeptide (GIP). Endocrine Reviews 16: 390–410
Figini M, Emanueli C, Grady EF et al. (1997) Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 272: G785–G793
Fink H, Rex A, Voits M, Voigt JP (1998) Major biological actions of CCK — a critical evaluation of research findings. Exp Brain Res 123: 77–83
Flint A, Raben A, Astrup A, Hoist JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101(3): 515–520
Fricker LD, Adelman JP, Douglass J, Thompson RC, von Strandmann RP, Hutton J (1989) Isolation and sequence analysis of cDNA for rat carboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme. Mol Endocrinol 3: 666–6673
Frohman LA, Jansson JO (1986) Growth-hormone-releasing-hormone. Endocr Rev 7: 223–253
Geracioti TD Jr, Liddle RA (1988) Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 319: 683–688
Gnanapavan S, Kola B, Bustin SA (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87: 2988–2991
Göke B, Printz H, Koop I, Rausch U, Richter G, Arnold R, Adler G (1986) Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor. Pancreas 1: 509–515
Göke B, Fenchel K, Knobloch S, Arnold R, Adler G (1988) Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats. Pancreas 3: 576–579
Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B (1993) Exendin-4 is a high potency agonist and truncated exendin (9–39) amide a potent agonist at the GLP-1 (7–37) amide receptor of insulin-secreting β-cells. J Biol Chem 268: 19650–19655
Goodman OB, Krupnick JG, Santini F et al. (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383: 447–450
Gossrau R (1979) Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemical and biochemical study. Histochem 60: 231–248
Goulon M, Rapin M, Charleux H et al. (1966) Watery diarrhea and hypokalemia associated with a non-insulin-secreting islet cell tumor. Apropos of a case with immediate and defintive cure of the diarrhea by tumoral excision. Nosologic discussion of this syndrome and Zollinger Ellison syndrome. Bull Mem Soc Med Hop Paris 117: 623–646
Greenberg R, Haddad R, Kashtan H, Kaplan O (2000) The effects of somatostatin and octreotide on experimental and human acute pancreatitis. J Lab Clin Med 135: 112–121
Guard S, Watson SP (1991) Tachykinin receptor types: Classification and membrane signalling mechanisms. Neurochem Int 18: 149–165
Gutkind JS (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839–1842
Hanahan D (1989) Transgenic mice as probes into complex systems. Science 246: 1265–1275
Hansen L, Deacon CF, Orskov C, Hoist JJ (1999) Glucagon-like peptide-1-(7–36) amide is transformed to glucagon-like peptide-1-(9–36) amide by DPP IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140: 5356–5363
Hansen L, Hartmann B, Bisgaard T, Mineo H, Jorgensen PN, Hoist JJ (2000) Somatostatin restrains the secretion of glucagons-like peptide and 2 from isolated perfused porcine ileum. Am J Physiol 278(6): E1010–E1018
Hansotani T, Drucker JD (2005) GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Reg Peptides 128: 125–134
Hardikar AA (2004) Role of incretins in pancreas growth and development. J Pancreas (online) 5: 454–456
Harmar AJ, Arimura A, Gozes I et al. (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50: 265–270
Harper AA, Raper HS (1943) Pancreozymin, a stimulant of secretion of pancreatic enzymes in extracts of the small intestine. J Physiol 102: 115–125
Hartmann B, Harr MB, Jeppesen PB, Wojdemann M, Deacon CF, Mortensen PB, Hoist JJ (2000) In vivo and in vitro degradation of glucagon-like peptide-2 in humans. J Clin Endocrinol Metab 85: 2884–2888
Havu N (1986) Enterochromaffin-like cell carcinoids of gastric mucosa in rats after lifelong inhibition of gastric secretion. Digestion 35Suppl 1: 42–55
Hazelwood RL (1993) The pancreatic polypeptide (PP-fold) family: Gastrointestinal, vascular, and feeding behavioural implications. Proc Soc Exp Biol Med 202: 44–63
Heinrich G, Gros P, Habener JF (1984) Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon. J Biol Chem 259: 14082–14087
Herbach N, Göke B, Schneider M, Hermanns W, Wolf E, Wanke R (2005) Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development. Reg Peptides 125: 103–117
Hershey AD, Krause JE (1990) Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 247: 958–962
Hoist JJ (2003) Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors. Adv Exp Med Biol 524: 263–279
Hoist JJ, Fahrenkrug J, Knuhtsen S, Jensen SL, Nielsen OV, Lundberg JM, Hokfelt T (1987) VIP and PHI in the pig pancreas: Coexistence, corelease, and kooperative effects. Am J Physiol 253: G13–G19
Holtmann MH, Hadac EM, Miller LJ (1995) Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270: 14394–14398
Holz GG, Kuhtreiber WM, Habener JF (1993) Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7–37). Nature 361: 362–365
Holzer P, Holzer-Petsche U (1997) Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 73: 173–217
Hosoda H, Kojima M, Matsuo H (2000) Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275: 21995–22000
Howard AD (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974–977
Hwa JJ, Witten MB, Williams P et al. (1999) Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am J Physiol 277: R1428–R1434
Inui A (2001) Ghrelin: An orexigenic and somatotrophic signal from the stomach. Nature Rev Neuroscience 2: 551–560
Ishihara T, Nakamura S, Kaziro Y, Takahashi T, Takahashi K, Nagata S (1991) Molecular cloning and expression of a cDNA encoding the secretin receptor. Eur Mol Biol Organ J 10: 1635–1641
Ivy AC, Oldberg E (1928) A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 65: 599–613
Jeppesen PB, Hartmann B, Thulesen J et al. (2001) Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120: 806–815
Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD (2001) Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121: 1380–1390
Jin HO, Song CW, Chang TM, Chey WY (1994) Roles of gut hormones in negative feedback regulation of pancreatic exocrine secretion in humans. Gastroenterology 107(6): 1828–1834
Kato T, Nagatsu T, Fukasawa K, Harada M, Nagatsu I, Sakakibara S (1978) Successive cleavage of N-terminal Arg1-Pro2 and Lys3-Pro4 from substance P but no release of Arg1-Pro2 from bradykinin, by X-Pro dipeptidyl-aminopeptidase. Biochim Biophys Acta 525: 417–422
Kimball CP, Murlin JR (1923) Aqueous extracts of pancreas. J Biol Chem 58: 337–346
Kimmel JR, Hayden LJ, Pollock HG (1975) Isolation and characterization of a new pancreatic polypeptide hormone. J Biol Chem 250: 9369–9376
Koh TJ, Goldenring JR, Ito S (1997) Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 113: 1015–1025
Kojima M, Hosoda H, Date Y (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656–660
Kolligs F, Fehmann HC, Göke R, Göke B (1995) Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9–39) amide. Diabetes 44:16–19
Kopin AS, Lee YM, McBride EW et al. (1992) Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA: 89: 3605–3609
Kramer MS, Cutler N, Feighner J, Shrivastava, Carman J et al. (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640–1645
Kvols LK, Moertel CG, O’Connell MJ, Schutt AJ, Rubin J, Hahn RG (1986) Treatment of the malignant carcinoid syndrome: Evaluation of a long-acting somatostatin analogue. N Engl. J Med 315: 663–666
La Barre J, Still EU (1930) Studies on the physiology of secretin. Am J Physiol 91: 649–653
Lamberts S, Van Der Lely AJ, De Herder W, Hofland L (1996) Octreotide. N Engl J Med 334: 246–254
Larhammar D (1996) Evolution of neuropeptide Y, peptide YY, and pancreatic polypeptide. Regul Pept 62: 1–11
Larssin et al. (1990) Is the reduction of VIP the clue to the pathophysiology of Hirschsprung’s disease? Z Kinderchir 45: 164
Larsson LI (1980) Gastrointestinal cells producing endocrine, neurocrine and paracrine messengers. Clin Gastroenterol 9: 485–516
Larsson LI, Sundler F, Hakanson R (1976) Pancreatic Polypeptide — a postulated new hormone: Identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia 12: 211–226
Lewis JT, Dayanandan B, Habener JF, Kieffer TJ (2000) Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: Demonstration by a receptor antagonist. Endocrinology 141(10): 3710–3716
Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ (2003) Glucagon-like peptide-1 receptor signalling modulates beta cell apoptosis. J Biol Chem 278: 471–478
Liddle RA (1994) Gastrin. In: Walsh JH, Dockray GJ (ed) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 175–216
Liddle RA (2000) Regulation of cholecystokinin secretion in humans. J Gastroenterol 35: 181–287
Lin TM, Evans DC, Chance RE, Spray GF (1977) Bovine pancreatic peptide: Action on gastric and pancreatic secretion in dogs. Am J Physiol 232: E311
Lloyd KC, Grandt D, Aurang K, Eysselein VE, Schmiczek M, Reeve JI, (1996) Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol 270: G123–G127
Lovshin J, Drucker DJ (2000) New frontiers in the biology of GLP-2. Regul Pept 90: 27–32
Makhlouf GM (1997) A century of regulatory peptides: From discovery to function. Gastroenterology 112: 2111–2113
Mannon P, Taylor IL (1994) The pancreatic polypeptide family. In: Walsh JH, Dockray GJ (eds) Gut peptides: Biochemistry and physiology. Raven Press, New York, pp 341–370
Mantyh CR, Gates TS, Zimmerman RP et al. (1988) Receptor binding sites for substance P, but not substance K, or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules insurgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85: 3235–3239
Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368–376
Martinez V, Tache Y (2000) Bombesin and the brain-gut axis. Peptides 21: 1617–1625
Matsas R, Fulcher IS, Kenny AJ, Turner AJ (1983) Substance P and [Leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 80: 3111–3115
Mayer EA, Baldi JP (1991) Can regulatory peptides be regarded as words of a biological language? Am J Physiol 261: G171–G184
Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55: 167–194
McDougall JK, Dunn AR, Jones KW (1972) In situ hybridization of adenovirus RNA and DNA. Nature 236: 346–348
McIntyre N, Holdsworth CD, Turner DS (1964) New interpretation of oral glucose tolerance. Lancet II: 20–21
Medeiros MD, Turner AJ (1994) Processing and metabolism of peptide YY: Pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 134: 2088–2094
Meier JJ, Gallwitz B, Siepmann N, Hoist JJ, Deacon CF, Schmidt WE, Nauck MA (2003) Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagons secretion in healthy human subjects at euglycaemia. Diabetologia 46: 798–801
Michel MC, Beck-Sickinger A, Cox H, Doods HN (1998) International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143
Miyawaki K, Yamada Y, Yano H et al. (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96(26): 14843–14847.
Miyawaki K, Yamada Y, Ban N et al. (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8(7): 738–742
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranscriptional processing. J Biol Chem 261: 11880–11889
Munroe DG, Gupta AK, Kooshesh P et al. (1999) Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96: 1569–1573
Murray CDR, Kamm MA, Bloom SR, Emmanuel AV (2003) Ghrelin for the gastroenterologist: history and potential. Gastroenterology 125: 1492–1502
Murthy KS, Grider JR, Jin JG (1995) Interplay of VIP and nitric oxide in regulation of neuromuscular activity in the gut. Arch Int Pharmacodyn Ther 329: 27–38
Mutt V (1980) Secretin: Isolation, structure and functions. In: Glass GBJ (ed) Gastrointestinal hormones. Raven Press, New York, pp 85–126
Mutt V, Magnusson S, Jorpes JE, Dahl E (1966) Structure of porcine secretin I. Biochem J 4: 2358
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) Ghrelin is a physiological mediator of feeding and acts through neuropeptide Y and agouti-related protein in the hypothalamus. Nature 409: 194–198
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W (1993 a) Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-l-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. J Clin Endocrinol Metab 76: 912–917
Nauck MA, Heimesaat MM, Orskov C, Hoist JJ, Erbert R, Creutzfeldt W (1993 b) Preserved incretin activity of glucagon-like peptide 1 (7-36)amide but not of synthetic human gastric inhibitory polypeptide in patients with type 2 diabetes mellitus. J Clin Invest 91: 301–307
Nawa H, Kotani H, Nakanishi S (1984) Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312: 729–734
Onaga T, Zabielski R, Kato S (2002) Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23: 279–290
Otsuka M, Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73: 229–308
Palmieri FE, Ward PE (1983) Mesentery vascular metabolism of substance P. Biochim Biophys Acta 755: 522–525
Parker JC, Andrews KM, Rescek DM et al. (1989) Structure-function analysis of a series of glucagon-like peptide 1 analogs. J Peptide Res 52: 398–409
Patel YC, Murthy KK, Escher EE, Banville D, Spiess J, Srikant CB (1990) Mechanism of action of somatostatin: An overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 39Suppl 2: 63–69
Pedrazzini T, Seydoux J, Kunstner P, et al. (1998) Cardiovascular response, feeding behaviour and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4: 722
Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: Studies in normal and diabetic subjects. J Clin Invest 46: 1954–1962
Peterson H, Solomon T, Grossman MI (1978) Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats. Am J Physiol 234: E286–E293
Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. 3: 639–650
Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G protein-coupled receptor kinases. Ann Rev Biochem 67: 653–692
Qu X, Xiao D, Weber HC (2003) Biologic relevance of mammalian bombesin like peptides and their receptors in human malignancies. Curr Opin Endocrinol Diabetes 10: 60–71
Read NW, McFarlane A, Kinsman RI et al. (1984) Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 86: 274–280
Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev 24: 389–427
Raulf F, Perez J, Hoyer D, Bruns C (1994) Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 55Suppl 3: 46–53
Regnier F (1983) High-performance liquid chromatography of biopolymers. Science 222: 245–252
Rehfeld JF (1998 a) How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regulatory Peptides 78: 31–39
Rehfeld JF (1998b) Processing of precursors of gastroenteropancreatic hormones: Diagnostic significance. J Mol Med 76: 338–345
Rehfeld JF (1998 c) The new biology of gastrointestinal hormones. Physiol Rev 78: 1087–1108
Rehfeld JF, Goetze JP (2003) The posttranslational phase of gene expression: New possibilities in molecular diagnosis. Curr Mol Med 3: 25–38
Rindi G, Ratineau C, Ronco A, Candusso ME, Tsai M, Leiter AB (1999) Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development 126: 4149–4156
Rocca AS, Brubaker PL (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140: 1687–1694
Rosenfeld MG, Mermod JJ, Amara SG et al. (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304: 129–135
Ruiz-Grande C, Pintado J, Alarcon C, Castilla C, Valverde I, Lopez-Novoa JM (1990) Renal catabolism of human glucagon-like peptides 1 and 2. Can J Physiol Pharmacol 68: 1568–1573
Saad MF, Bernaba B, Hwu CM (2002) Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87: 3997–4000
Schäfer G, Nau R, Cole T, Conlon M (1986) Specific binding and proteolytic inactivation of bradykinin by membrane vesicles from pig intestinal smooth muscle. Biochem Pharmacol 35: 3719–3725
Schirra J, Göke B (2005) The physiological role of GLP-1 in human: Incretin, ileal brake or more ? Reg Peptides: 128: 109–115
Schirra J, Katschinski M, Weidmann C, Schäfer T, Wank U, Arnold R, Göke B (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97: 92–103
Schirra J, Stumm K, Leicht P, Arnold R, Göke B, Katschinski M (1998) Exendin (9-39) amide is an antagonist of glucagon-like peptide 1 (7-36) amide in human. J Clin Invest 101: 1421–1430
Schirra J, Houk P, Wank U, Arnold R, Göke B, Katschinski M (2000) Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans. Gut 56: 622–631
Schmidt WE, Bojko JB (1999) Regulation of gastric acid secretion. In: HG Greeley (ed) Gastrointestinal endocrinology. Humana, Totowa, NJ, pp 353–391
Schwartz GJ (2000) The role of gastrointestinal vagal afferents in the control of food intake; current prospects. Nutrition 16: 866–873
Schwartz TW (1986) The processing of peptide precursors. „Proline-directed arginyl cleavage“ and other monobasic processing mechanisms. FEBS Lett 200: 1–10
Severini C, Improta G, Falonieri-Erspamer G, Salvadiri S, Erspamer V (2002) The tachykinine peptide family. Pharmacol Rev 54: 285–322
Sherwood NM, Krueckl SL, McRoy JE (2000) The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagons superfamiliy. Endocrine Reviews 21: 619–670
Smith JP, Solomon TE, Bagheri S, Kramer S (1990) Cholecystokinin stimulates growth of human pancreatic adenocarcinoma. Dig Dis Sci 35: 1377–1384
Smith RG et al. (1997) Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18: 621–645
Solomon TE, Vanier M, Morisset (1983) Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol 245: G99–G105
Spannagel AW, Green GM, Guan D, Liddle RA, Faull K, Reeve JR (1996) Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci USA 93: 4415–4420
Spengler B, Kirsch D, Kaufmann R, Jaeger E (1992) Peptide sequencing by matrix-assisted laser-desorption mass spectrometrie. Rapid Commun Mass Spec 6: 105–108
Spiegel K, Tasali E, Penev P, Cauter EV (2004) Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141: 846–850
Spiller RC, Trotman IF, Higgins BE et al. (1984) The ileal brake inhibition of jejunal motility after ileal fat perfusion in man. Gut 25: 365–374
Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313: 745–747
Sussman KE, Vaughan GD, Timmer RF (1966) An in vitro method for studying insulin secretion in the perfused isolated rat pancreas. Metabolism 15: 466–476
Takahashi Y, Fukushige S, Murotsu T, Matsubara K (1986) Structure of human cholecystokinine gene and its chromosomal location. Gene 50: 353–360
Takeda J, Seino Y, Tanaka K et al. (1987) Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor. Proc Natl Acad Sci USA 84: 7005–7008
Thomas RP, Hellmich MR, Townsend CM, Evers BM (2003) Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocrine Reviews 24: 571–599
Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J (1998) Gastrin and colorectal cancer: A prospective study. Gastroenterology 115: 275–280
Trimble ER, Bruzzone R, Biden TJ, Meehan CJ, Andreu D, Merrifeld RB (1987) Secretin stimulates cyclic AMP and inositol triphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci USA 84: 3146–3150
Trümper A, Trümper K, Trusheim H, Arnold R, Göke B, Hörsch D (2001) Glucose-dependent insulinotropic poly-peptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol 15: 1559–1570
Tschöp M, Wexer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707–709
Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM (1996) Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98(11): 2440–2445
Turton MD, O’Shea D, Gunn I et al. (1996) A role for glucagon-like peptide 1 in the central regulation of feeding. Nature 379: 69–72
Ueno N, Inui A, Iwamoto M et al. (1999) Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 117: 1427–1432
Unger RH, Ketterer H, Eisentraut AM (1966) Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 15: 865–867
Urosawa IA, Farilla L, Hui H, D’Amico E, Perfetti R (2004) GLP-1 inhibition of pancreatic islet cell apoptosis. Trends Endocrinol Metab 15: 27–33
Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861–2870
Valenzuela JE, Schubert T, Fogel MR et al. (1989) A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 10: 958–961
Varner AA, Modlin IM, Walsh JH (1981) High potency of bombesin for stimulation of human gastrin release and gastric acid secretion. Regul Pept 1: 289–296
Vilsboll T, Krarup T, Deacon CF, Madsbad S, Hoist JJ (2001) Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50(3): 609–613
Walsh JH (1993) Gastrointestinal hormones: Past, present, and future. Gastroenterology 104: 653–657
Wang TC, Brand SJ (1992) Function and regulation of gastrin in transfenic mice: a review. Yale J Biol Med 65: 705–713
Wang Y, Prpic V, Green GM, Reeve JR, Liddle RA (2002) Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells. Am J Physiol Gastrointest Liver Physiol 282: G16–G22
Ward PE, Sheridan MA, Hammon KJ, Erdos EG (1980) Angiotensin I converting enzyme (kininase II) of the brush border of human and swine intestine. Biochem Pharmacol 29: 1525–1529
Wen J, Phillips SE, Sarr MG et al. (1995) PYY and GLP-1 contribute to feedback inhibition from the canine ileum and colon. Am J Physiol 169: G945–952
Wettergren A, Wojdemann M, Hoist JJ (1998) Glucagon-like peptide 1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol 275: G984–992
Williams JA (2001) Intracellular signalling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 63: 77–97
Wobus AM (2003) Zellkulturtechniken, Zellmodelle und Tissue Engineering. In: Ganten D, Ruckpaul K (Hrsg) Grundlagen der Molekularen Medizin, Springer, Berlin Heidelberg, S 255–291
Wolfe MM, Song DH, Jepeal LI, Moore TC (2003) Gastrin peptides: Pathophysiologic role in gastrointestinal carcinogenesis. Curr Opin Endocrinol Diabetes 10: 39–49
Wynick D, Anderson JV, Williams SJ, Bloom SR (1989) Resistance to metastatic pancreatic endocrine tumours after long-term treatment with the somatostatin analogue octreotide (SMS 201-995). Clin Endocrinol (Oxf) 30: 385–388
Xiao Q, Boushey RP, Drucker DJ, Brubaker PL (1999) Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117: 99–105
Xiao Q, Boushey RP, Cino M, Drucker DJ, Brukaber PL (2000) Circulating levels of glucagon-like peptide 2 in human subjects with inflammatory bowel disease. Am J Physiol 278: R1057–1063
Xu G, Staffers DA, Habener JF, Bonner-Weir S (1999) Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48(12): 2270–2276
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Göke, B., de Heer, J., Göke, R. (2006). Gastrointestinale Hormonsysteme und ihre Regulation. In: Ganten, D., Ruckpaul, K., Köhrle, J. (eds) Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28782-5_11
Download citation
DOI: https://doi.org/10.1007/3-540-28782-5_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28781-0
Online ISBN: 978-3-540-28782-7
eBook Packages: Life Science and Basic Disciplines (German Language)